杨宝峰, 孙建平, 李贵荣, StanleyNattel, 周晋, 高焕焕. III类抗心律失常药RP58866对豚鼠及犬内向整流及瞬时外向钾电流的作用J. 药学学报, 1999, 34(10): 730-733.
引用本文: 杨宝峰, 孙建平, 李贵荣, StanleyNattel, 周晋, 高焕焕. III类抗心律失常药RP58866对豚鼠及犬内向整流及瞬时外向钾电流的作用J. 药学学报, 1999, 34(10): 730-733.
Yang Baofeng, Sun Jianping, Li Guirong, Stanley Nattel, Zhou Jin , Gao Huanhuan, . EFFECTS OF NOVEL CLASS III ANTIARRHYTHMIC DRUG RP58866 ON IK1 AND Ito IN GUINEA PIG AND CANINE VENTRICULAR MYOCYTESJ. Acta Pharmaceutica Sinica, 1999, 34(10): 730-733.
Citation: Yang Baofeng, Sun Jianping, Li Guirong, Stanley Nattel, Zhou Jin , Gao Huanhuan, . EFFECTS OF NOVEL CLASS III ANTIARRHYTHMIC DRUG RP58866 ON IK1 AND Ito IN GUINEA PIG AND CANINE VENTRICULAR MYOCYTESJ. Acta Pharmaceutica Sinica, 1999, 34(10): 730-733.

III类抗心律失常药RP58866对豚鼠及犬内向整流及瞬时外向钾电流的作用

EFFECTS OF NOVEL CLASS III ANTIARRHYTHMIC DRUG RP58866 ON IK1 AND Ito IN GUINEA PIG AND CANINE VENTRICULAR MYOCYTES

  • 摘要: 目的:研究III类抗心律失常药RP58866 对IK1 ,瞬时外向钾电流(Ito) 的作用。方法:用豚鼠和犬离体心肌细胞及全细胞电压钳技术。结果:在- 100 m V 时,RP58866 以浓度依赖方式明显减少了豚鼠心室肌细胞IK1,其IC50为(3-4±0-8) μmol·L-1。在犬心室肌细胞,RP58866 可明显抑制Ito( 在100 μmol·L-1 时减少87% ±2-1% ),其IC50为(2-3±0-5) μmol·L-1 。结论:RP58866 对心肌细胞的IK1 和Ito 均有抑制作用,而不是一种特殊的IK1抑制剂。

     

    Abstract: AIM: Novel class III antiarrhythmic compounds RP58866 are known to block inward rectifier K+ current ( IK1), and have been used as “specific” probes for the physiologic role of IK1. However, the specificity is not completely established. The present study was designed to determine the effects of RP58866 on IK1 and transient outward K+ current (Ito) in isolated cardia myocytes. METHODS: The tight seal cell clamp technique was used. RESULTS: RP58866 significantly decreased IK1 in a concentration dependent manner, with an IC50 of (3. 4±0.8) μmol·L-1 (x±s) at -100 mV in guinea pig ventricular cells. In canine ventricular myocytes, RP58866 significantly inhibited Ito(decreased by 87%±2.1% at 100μmol·L-1) with IC50 an of (2.3±0.5) μmol·L-1. CONCLUSION: Our results suggest that RP58866 inhibits IK1 and Ito in cardiac myocytes with similar potency and that the compound is not a specific IK1 inhibitor.